Get the Weekly Intelligence Brief — top committee picks every Sunday.

ALGN vs OMDA

Align Technology vs Omada Health — AI-powered side-by-side comparison
ALGN
Align Technology
73
Buy
VS
OMDA
Omada Health
59
Buy
MetricALGNOMDA
AI Score 73 59
Price $172.86 $24.00
P/E Ratio 30.03× 353.61×
ROE 10.1% -5.6%
Revenue Growth YoY
Gross Margin 66.5% 68.2%
Debt / Equity 0.03× 0.00×
Dividend Yield 0.0% 0.0%
RSI (14) 55.1 66.6
Beta 1.653 1.7204
Expected Upside +7.7%

AI Committee View

Current Innellis committee reasoning for ALGN versus OMDA.
ALGN leads by 14 points.

ALGN scores 73/100 (Buy) versus OMDA at 59/100 (Buy).

ALGN Committee View
100% agreement
5 analysts

The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
OMDA Committee View
50% agreement
4 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 35.5% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
  • Bollinger bandwidth of 35.5% signals elevated volatility — Risk
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ALGN Full Analysis OMDA Full Analysis